These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16308844)

  • 1. Automated optimization of mass spectrometric parameters in 'Tune' mode for impure analytes in dirty samples using gradient high-performance liquid chromatography.
    Rogatsky E; Stein D
    Rapid Commun Mass Spectrom; 2005; 19(24):3759-60. PubMed ID: 16308844
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 4. Coupling ultra high-pressure liquid chromatography with single quadrupole mass spectrometry for the analysis of a complex drug mixture.
    Schappler J; Nicoli R; Nguyen D; Rudaz S; Veuthey JL; Guillarme D
    Talanta; 2009 Apr; 78(2):377-87. PubMed ID: 19203598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
    Yu K; Little D; Plumb R; Smith B
    Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a rapid and automated high performance liquid chromatography method development strategy for pharmaceutical drug candidates.
    Hewitt EF; Lukulay P; Galushko S
    J Chromatogr A; 2006 Feb; 1107(1-2):79-87. PubMed ID: 16406385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using liquid chromatography-ion trap mass spectrometry to determine pharmaceutical residues in Taiwanese rivers and wastewaters.
    Chen HC; Wang PL; Ding WH
    Chemosphere; 2008 Jun; 72(6):863-9. PubMed ID: 18499225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation.
    Kafkala S; Matthaiou S; Alexaki P; Abatzis M; Bartzeliotis A; Katsiabani M
    J Chromatogr A; 2008 May; 1189(1-2):392-7. PubMed ID: 18206895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-performance liquid chromatography coupled to linear ion trap mass spectrometry for the identification of drug metabolites in biological samples.
    Dear GJ; James AD; Sarda S
    Rapid Commun Mass Spectrom; 2006; 20(8):1351-60. PubMed ID: 16555373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel preparative high-performance liquid chromatography with on-line molecular mass characterization.
    Edwards C; Liu J; Smith TJ; Brooke D; Hunter DJ; Organ A; Coffey P
    Rapid Commun Mass Spectrom; 2003; 17(18):2027-33. PubMed ID: 12955730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of d-alpha-tocopherol and its impurity by chiral high performance liquid chromatography in pharmaceutical preparations.
    Kłaczkow G; Jakoniuk D; Anuszewska EL
    Acta Pol Pharm; 2004; 61(3):181-4. PubMed ID: 15481242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in high-throughput mass spectrometry.
    Morand KL; Burt TM; Regg BT; Tirey DA
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):729-35. PubMed ID: 11899612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some considerations regarding drug determinations in biological fluids with physico-chemical methodologies [proceedings].
    De Graeve J
    Ann Biol Clin (Paris); 1978; 36(3):161-8. PubMed ID: 360889
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and evaluation of a multi-detection system composed of ultraviolet, evaporative light scattering and inductively coupled plasma mass spectrometry detection for the analysis of pharmaceuticals by liquid chromatography.
    Pereira AS; Schelfaut M; Lynen F; Sandra P
    J Chromatogr A; 2008 Mar; 1185(1):78-84. PubMed ID: 18262535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-2 microm HPLC coupled with sub-ppm mass accuracy for analysis of pharmaceutical compound libraries.
    Stroh JG; Petucci CJ; Brecker SJ; Nogle LM
    J Sep Sci; 2008 Dec; 31(21):3698-703. PubMed ID: 18925622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of S-phenylmercapturic acid in human urine using an automated sample extraction and fast liquid chromatography-tandem mass spectrometric method.
    Li Y; Li AC; Shi H; Junga H; Jiang X; Naidong W; Lauterbach JH
    Biomed Chromatogr; 2006; 20(6-7):597-604. PubMed ID: 16779771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite.
    Schwartz MS; Desai RB; Bi S; Miller AR; Matuszewski BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):116-24. PubMed ID: 16716772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel supercritical fluid chromatography/mass spectrometry system for high-throughput enantioselective optimization and separation.
    Zeng L; Xu R; Laskar DB; Kassel DB
    J Chromatogr A; 2007 Oct; 1169(1-2):193-204. PubMed ID: 17900596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and application of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid-liquid extraction.
    Wang PG; Wei JS; Kim G; Chang M; El-Shourbagy T
    J Chromatogr A; 2006 Oct; 1130(2):302-7. PubMed ID: 16919649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.